209 related articles for article (PubMed ID: 35556169)
21. Long-term outcomes of 530 esophageal squamous cell carcinoma patients with minimally invasive Ivor Lewis esophagectomy.
Qi W; Zixiang W; Tianwei Z; Shuai F; Sai Z; Gang S; Ming W
J Surg Oncol; 2018 Apr; 117(5):957-969. PubMed ID: 29878389
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
23. The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy.
Xu Z; Ke H; Zheng B; Lin C; Zhang Y; Wang L; Lin Y; Ye Y; Cai L; You M; Chen J; Xu Y
Cancer Control; 2023; 30():10732748231185025. PubMed ID: 37339928
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram.
Shao CY; Liu XL; Yao S; Li ZJ; Cong ZZ; Luo J; Dong GH; Yi J
Eur J Surg Oncol; 2021 Jun; 47(6):1473-1480. PubMed ID: 33349524
[TBL] [Abstract][Full Text] [Related]
25. The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma.
Lv X; Han S; Xu B; Deng Y; Feng Y
BMC Cancer; 2021 Sep; 21(1):1072. PubMed ID: 34592957
[TBL] [Abstract][Full Text] [Related]
26. Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
Wang Q; Wu Z; Zhan T; Fang S; Zhang S; Shen G; Wu M
BMC Cancer; 2019 May; 19(1):500. PubMed ID: 31132995
[TBL] [Abstract][Full Text] [Related]
27. Nomogram based on circulating lymphocyte subsets for predicting radiation pneumonia in esophageal squamous cell carcinoma.
Zhang XZ; Tao SP; Liang SX; Chen SB; Liu FS; Jiang W; Chen MJ
Front Immunol; 2022; 13():938795. PubMed ID: 36105795
[TBL] [Abstract][Full Text] [Related]
28. Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Chao YK; Chang HK; Tseng CK; Liu YH; Wen YW
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868287
[TBL] [Abstract][Full Text] [Related]
29. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
30. Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
Chen D; Wang W; Mo J; Ren Q; Miao H; Chen Y; Wen Z
BMC Cancer; 2021 Feb; 21(1):145. PubMed ID: 33563244
[TBL] [Abstract][Full Text] [Related]
31. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
32. Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3.
Sun Y; Wang J; Li Y; Pan S; Yang T; Sun X; Wang Y; Shi X; Zhao X; Zhang X
Future Oncol; 2019 Jan; 15(2):121-132. PubMed ID: 30232909
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma.
Han L; Song Q; Jia Y; Chen X; Wang C; Chen P; Min R; Cheng Y
Tumour Biol; 2016 Mar; 37(3):3081-90. PubMed ID: 26423404
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive complication index as a prognostic factor in minimally invasive esophagectomy for esophageal squamous cell carcinoma.
Kudo T; Oshikiri T; Goto H; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
Esophagus; 2022 Jul; 19(3):410-416. PubMed ID: 35220510
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of MRI-based radiomics signatures models for prediction of disease-free survival and overall survival in patients with esophageal squamous cell carcinoma.
Chu F; Liu Y; Liu Q; Li W; Jia Z; Wang C; Wang Z; Lu S; Li P; Zhang Y; Liao Y; Xu M; Yao X; Wang S; Liu C; Zhang H; Wang S; Yan X; Kamel IR; Sun H; Yang G; Zhang Y; Qu J
Eur Radiol; 2022 Sep; 32(9):5930-5942. PubMed ID: 35384460
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
Zhou F; Zhu M; Wang M; Qiu L; Cheng L; Jia M; Xiang J; Wei Q
J Transl Med; 2016 May; 14(1):154. PubMed ID: 27246611
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
38. Prognostic evaluation of esophageal cancer patients with stages I-III.
Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
[TBL] [Abstract][Full Text] [Related]
39. Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally invasive Esophagectomy).
Yang Y; Zhang X; Li B; Li Z; Sun Y; Mao T; Hua R; Yang Y; Guo X; He Y; Li H; Chen H; Tan L
BMC Cancer; 2019 Jun; 19(1):608. PubMed ID: 31226960
[TBL] [Abstract][Full Text] [Related]
40. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
